Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping-Reference-Cited by-同舟云学术

Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping

Published:2024-08-29 Issue: Volume: Page:
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Klos Corentine,Roynard Pauline,Berthon Céline,Soenen Valérie,Marceau Alice,Fournier Elise,Fenwarth Laurene,Daudignon Agnès,Roche Catherine,Guermouche Hélène^ORCID

Funder

Centre Hospitalier Universitaire de Lille

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05948-w.pdf

Reference5 articles.

1. Khoury JD, Solary E, Abla O et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia 36(7):1703–1719. https://doi.org/10.1038/s41375-022-01613-1

2. Assaf N, Liévin R, Merabet F et al (2021) KMT2A-ARHGEF12, a therapy related fusion with poor prognosis. Mol Biol Rep 48(10):7021–7027. https://doi.org/10.1007/s11033-021-06621-5

3. Schafernak KT, Williams JA, Clyde BI, Marcus C, Decker B, Toydemir RM (2021) Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma. Cancer Genet 258–259:23–26. https://doi.org/10.1016/j.cancergen.2021.06.006

4. Issa GC, Aldoss I, DiPersio J et al (2023) The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature 615(7954):920–924. https://doi.org/10.1038/s41586-023-05812-3

5. Garg S (2023) Towards routine chromosome-scale haplotype-resolved reconstruction in cancer genomics. Nat Commun 14(1):1358. https://doi.org/10.1038/s41467-023-36689-5. (Published 2023 Mar 13)